← All indications
Neuromuscular Junction Diseases
Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.
Subtype terms (3)
More specific conditions that are subtypes of Neuromuscular Junction Diseases in the MeSH hierarchy.
- Botulism
11 drugs (6 approved, 5 experimental)
- Myasthenia Gravis
93 drugs (51 approved, 42 experimental)
- Myasthenic Syndromes, Congenital
5 drugs (3 approved, 2 experimental)
Drugs by status
Phase 3 trials (2)